HCA Healthcare reported Q3 2024 revenues of $17.487 billion, with net income reaching $1.270 billion or $4.88 per diluted share. Same facility admissions increased 4.5%, while emergency room visits rose 4.6% compared to Q3 2023. The results include a $0.15 per share impact from Hurricane Helene.The company maintained its 2024 guidance but expects results in the lower half of the range due to hurricane impacts. Hurricane-related expenses and revenue losses are estimated at $200-300 million for Q4 2024. Operating cash flows strengthened to $3.515 billion, up from $2.479 billion in Q3 2023.The Board declared a quarterly cash dividend of $0.66 per share, payable on December 27, 2024, to stockholders of record on December 13, 2024. During Q3, the company repurchased 4.948 million shares for $1.795 billion, with $2.433 billion remaining under its repurchase authorization.

HCA Healthcare reported Q3 2024 revenues of $17.487 billion, with net income reaching $1.270 billion or $4.88 per diluted share. Same facility admissions increased 4.5%, while emergency room visits rose 4.6% compared to Q3 2023. The results include a $0.15 per share impact from Hurricane Helene.The company maintained its 2024 guidance but expects results in the lower half of the range due to hurricane impacts. Hurricane-related expenses and revenue losses are estimated at $200-300 million for Q4 2024. Operating cash flows strengthened to $3.515 billion, up from $2.479 billion in Q3 2023.The Board declared a quarterly cash dividend of $0.66 per share, payable on December 27, 2024, to stockholders of record on December 13, 2024. During Q3, the company repurchased 4.948 million shares for $1.795 billion, with $2.433 billion remaining under its repurchase authorization.